课题基金 / 基金详情

项目摘要

项目成果

Gabriel Lazaro-Munoz的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (Supplement) Psychiatric genetics researchers have recently identified numerous genomic loci associated with schizophrenia, depression, autism spectrum disorder, bipolar disorder, attention deficit hyperactivity disorder, and other disorders. The identification of these genomic loci makes it possible to generate polygenic risk scores (PRS) to stratify an individual’s risk for different psychiatric disorders compared to the general population. The usual age of onset for most psychiatric disorders is during childhood, late adolescence, and early adulthood. As many as 20% of children and adolescents in the U.S. have a diagnosable psychiatric disorder. Numerous studies suggest that early intervention improves clinical outcomes, however, the average duration of untreated symptoms and disorders is generally in the order of years. Thus, there is great need for tools such as PRS to help improve the identification of children and adolescents at higher risk for psychiatric disorders in order to take steps to potentially prevent or delay the onset of disease, minimize morbidity and risk for suicide, or provide early intervention. The promise of reliable PRS in mental health care and prevention is considerable, but there are critical potential ethical and policy challenges. For example: which children and adolescents, if any, should be tested; when, if at all, should children and adolescents be tested; where should they be tested; should PRS testing require a clinician’s order or could it be done through direct-to-consumer services; who should have access to children and adolescents’ psychiatric PRS results; how should these results be used; what kind of impact would PRS results have on children and adolescents who are at increased risk; how may high PRS impact parents/guardians’ expectations and parenting practices; would PRS exacerbate or decrease mental health stigma and self-stigma for those identified to be at higher risk? The long-term goal of this research is to develop ethically-justified and empirically-informed guidelines and tools to address the ethical and policy challenges raised by the use of psychiatric PRS with children and adolescents. The objective of this supplement, which is the first step in pursuit of this goal, is to identify child and adolescent psychiatrists’ knowledge, practices, attitudes, expectations, and perceived benefits and risks about the use of psychiatric PRS. To achieve this objective, we will first use the Delphi technique with expert child and adolescent psychiatrists to develop the “PRS in Child and Adolescent Psychiatry Survey.” Then, we will administer the survey to child and adolescent psychiatrists and examine correlates of outcomes. Next steps include developing an R01 application to more comprehensively examine ethical principles and develop ethically-justified guidelines to promote the responsible use of psychiatric PRS with children and adolescents.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41431-020-00738-0
发表时间: 2021-03
期刊: European journal of human genetics : EJHG
影响因子: --
作者: [Lázaro-Muñoz G, Torgerson L, Smith HS, Pereira S]
通讯作者: Pereira S
Psychiatric genetics researchers' views on offering return of results to individual participants.
精神病遗传学研究人员对向个人参与者提供结果回报的看法。
DOI: 10.1002/ajmg.b.32682
发表时间: 2019-12
期刊: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
影响因子: --
作者: [Kostick KM, Brannan C, Pereira S, Lázaro-Muñoz G]
通讯作者: Lázaro-Muñoz G
DOI: 10.1038/s41436-020-00986-x
发表时间: 2021-03
期刊: Genetics in medicine : official journal of the American College of Medical Genetics
影响因子: --
作者: [Lázaro-Muñoz G, Torgerson L, Pereira S]
通讯作者: Pereira S
DOI: 10.1038/s41436-020-01019-3
发表时间: 2021-03
期刊: Genetics in medicine : official journal of the American College of Medical Genetics
影响因子: --
作者: [Lázaro-Muñoz G, Pereira S, Carmi S, Lencz T]
通讯作者: Lencz T
7
    Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
    • 批准号:
      10696946
    • 项目类别:
    • 资助金额:
      $61.67万
    • 财政年份:
      2021
    • 负责人:
      Gabriel Lazaro-Munoz
    • 依托单位:
    Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
    • 批准号:
      10483181
    • 项目类别:
    • 资助金额:
      $62.22万
    • 财政年份:
      2021
    • 负责人:
      Gabriel Lazaro-Munoz
    • 依托单位:
    Polygenic Risk Scores in Child and Adolescent Psychiatry: Ethical, Clinical, and Legal Implications
    • 批准号:
      10355758
    • 项目类别:
    • 资助金额:
      $65.54万
    • 财政年份:
      2021
    • 负责人:
      Gabriel Lazaro-Munoz
    • 依托单位:
    Ethical Legal and Social Implications of Translational Psychiatric Genomics Research
    海外基金